Part,  Chapter, Paragraph

 1   II,     5.  4.  4|        than 30 times the dialysis/transplant incidence of Cyprus), so
 2   II,     5.  4.  4|        the prevalence of dialysis/transplant among countries is even
 3   II,     5.  7.  1|     treating patients living on a transplant are indeed by one-third
 4   II,     5.  7.  1|          90~585.1~1-5 T if kidney transplant recipient~ ~2~Kidney damage~
 5   II,     5.  7.  2|             European Dialysis and Transplant Association (ERA-EDTA) that
 6   II,     5.  7.  3|       mortality risk reduction in transplant recipients was much higher:
 7   II,     5.  7.  3|   Although the better survival of transplant recipients is, at least
 8   II,     5.  7.  5|        improve organ donation and transplant activity. In 2002 new regulations
 9   II,     5.  7.  5|   prevention, dialysis and kidney transplant.~· The Austrian Ministry
10   II,     5.  7.  6|     quality of life are higher in transplant recipients compared to dialysis
11   II,     5.  7.  7|           to an end? Nephrol Dial Transplant 2007;22:678-80.~Jager KJ,
12   II,     5.  7.  7|          strategies. Nephrol Dial Transplant 2001;16 Suppl 7:57-60~Lin
13   II,     5.  7.  7|         assessments. Nephrol Dial Transplant 2006 Jul;21(7):1899-905.~
14   II,     5.  7.  7|           1990-1999. Nephrol Dial Transplant 2003 Sep;18(9):1824-33.~
15   II,     5.  7.  7|           1998-2002. Nephrol Dial Transplant 2006 Aug;21(8):2178-83.~
16   IV,    11.  5.  1|        with a transplanted organ. Transplant procedures continue to develop
17   IV,    11.  5.  1|   institutional centred, national transplant organizations (NTOs) based
18   IV,    11.  5.  1|          different models, the EU transplant geography can be split into
19   IV,    11.  5.  1|        exception of UKTSA (the UK Transplant Service Authority), virtually
20   IV,    11.  5.  1|        the birth of international transplant exchange organizations in
21   IV,    11.  5.  2|        Data sources~ ~A number of transplant organizations and scientific
22   IV,    11.  5.  2|        operate in Europe~European transplant organizations on web:~ ~
23   IV,    11.  5.  2|          ESOT) ( w ~ ~EU National transplant organizations on web:~-
24   IV,    11.  5.  2|         and Croatia : ~ ~European transplant physician and organ procurement
25   IV,    11.  5.  2|           on web:~- Collaborative Transplant Study (Heidelberg University ): h
26   IV,    11.  5.  2|      Registry: htt European Liver Transplant Registry: htt International
27   IV,    11.  5.  2|               International Islet Transplant Registry: htt Italian Dyalisis
28   IV,    11.  5.  2|              Italian Dyalisis and Transplant Registry (RIDT): ht ISHLT
29   IV,    11.  5.  2|          REDMO): ht Spanish Liver Transplant Registry: htt DOPKI: htt
30   IV,    11.  5.  2|        DOPKI: htt ALLIANCE-O: htt Transplant Procurement Management: htt
31   IV,    11.  5.  3|      assessment criteria in organ transplant~ ~Most of the risk assessment
32   IV,    11.  5.  3|         Biological tests in organ transplant~ ~As Figure 11.16 shows,
33   IV,    11.  5.  4|           in Europe waiting for a transplant. Mortality rates while waiting
34   IV,    11.  5.  4|        for a heart, liver or lung transplant usually range from 15 to
35   IV,    11.  5.  4|        the scarcity of organs for transplant is trafficking of human
36   IV,    11.  5.  4|           was to become known as “transplant tourism” when prosperous
37   IV,    11.  5.  4|       improved the functioning of transplant systems.~In order to expand
38   IV,    11.  5.  4|          represents 17% of kidney transplant activity and 5% of liver
39   IV,    11.  5.  4|     strong evidence of favourable transplant outcome and low donor risk.~
40   IV,    11.  5.  4| importance of having an efficient transplant system in place ensuring
41   IV,    11.  5.  4|         establishment of adequate transplant systems at national level.
42   IV,    11.  5.  4|        the local actors (hospital transplant teams and transplant coordinators)
43   IV,    11.  5.  4|     hospital transplant teams and transplant coordinators) in the decision-making
44   IV,    11.  5.  4|       Scandiatransplant, European Transplant Network or the regular meetings
45   IV,    11.  5.  4|           into every stage of the transplant process in order to improve
46   IV,    11.  5.  4|      risk-benefit analysis by the transplant team. Risks and characteristics
47   IV,    11.  5.  4|      necessary documentation.~The transplant system must ensure traceability
48   IV,    11.  5.  4|     consequences of not getting a transplant.~ ~
49   IV,    11.  5.  5|  situation of the research in the transplant field at European level:~ ~
50   IV,    11.  5.  5|        the actors involved in the transplant process: healthcare professionals,
51   IV,    11.  5.  5|           An article published on Transplant International written by
52   IV,    11.  5.  5|          European position in the transplant field; therefore, the European
53   IV,    11.  5.  5|          issues in organ and cell transplant in order to join forces
54   IV,    11.  5.  5|       cells (CSE) and solid organ transplant therapies,~2. new cell therapies
55   IV,    11.  5.  5|           for CSE and solid organ transplant,~3. innovative training
56   IV,    11.  5.  5|       whole staff involved in the transplant and research in the field
57   IV,    11.  5.  5|      mobilisation of the European transplant community. To examine the
58   IV,    11.  5.  5|   donation process, to grow to be Transplant Coordinators and lead organ
59   IV,    11.  5.  5|           a European donation and transplant activity registry for delivering
60   IV,    11.  5.  6|   responsible for organ donation (transplantdonor co-ordinators”)~2004Guide 4)~
61   IV,    11.  5.  6|           the management of organ transplant waiting lists and waiting
62   IV,    11.  5.  6|        experience acquired by the transplant surgical and medical teams.~ ~
63   IV,    11.  5.  7|         addressing a strengthened transplant cooperation among Member
64   IV,    11.  6.  5|      towards novel opportunities? Transplant International 2007, distributed
65  Key,   Ap5.  0.  0|           trafficking~transfusion~transplant~transplantation~transplanted~